Clinical Trials

• NCT05506943

  A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen

  This study is currently enrolling.

  Associated Conditions: Biliary Tract Cancer

  Research Area: Clinical Cancer Research

  Research Location: Orlando, Florida